CVRx | Barostim
Avatar

Considering Quality of Life as Part of Patient Selection for Heart Failure Therapies

By CVRx | Barostim FEATURING Luanda Grazette
By CVRx | Barostim FEATURING Luanda Grazette
88 views
April 28, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
10:51
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. M. PEREZ-IZQUIERDO
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
06:59
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling, M. PEREZ-IZQUIERDO
10:51
CVRx | Barostim

Our Experience with Barostim in over 40 Patients to Date

Feat. P. Mccann
14:36
CVRx | Barostim

Barostim in the EP's HFrEF Toolbox

Feat. R. Alimohammad
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
12:50
AVA at Your Fingertips

Lessons Learned From Trials of Implementation: The CLABSI Section of…

Feat. V. Chopra
35:06
The New Orleans Conference

What Is Truly Informed Consent and Should The Perfusionist Get His/H…

08:49
PERT Consortium 2021

Regulatory Pathways for Devices for Management of Pulmonary Embolism…

Feat. S. Lossef
30:09
Innovations in Cardiovascular Therapeutics 2016

Understanding the changing landscape of cardiovascular economics

11:19
PERT Consortium 2021

Regulatory Pathways for PE Management: Panel Discussion

Feat. K. Rosenfield, B. Keeling, S. Lossef, T. Bowers, E. Secemsky
12:45
American Society of Echocardiography

Strategies to Reduce Low Value Care

Feat. G. Rose
06:34
The Texas Heart Institute

Artificial Intelligence in Medicine: What Is the Difference Between …

Feat. Z. Krajcer, B. Aazhang, M. Razavi
08:16
Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

The Sunshine Act - Understanding the Ins and Outs

Feat. S. Noor
20:46
Corey Howard

The Very Real Threat to Patient Access: Ongoing Medicare Physician C…

Feat. L. Bucshon, S. Ransone, C. Yag-Howard, T. Cronin
16:21
American Heart & Vascular Institute

Implications of New Ambulatory Payment Models for Percutaneous Inter…

Feat. S. Khan
58:25
Rush Heart

Medicare Quality Payment Program Overview: A Micro View of MACRA

Feat. K. Williams
16:19
Cardiometabolic Health Congress (CMHC)

Navigating the Web of the Prescription Approval and Appeals Process:…

Feat. M. Stryker
13:14
13th Orange County Symposium for Cardiovascular Disease Prevention

Is CVD Prevention Too Difficult? Is It Too Expensive?

Feat. S. Greenfield
10:52
Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

ACO A New Form of HMO - Is it Detrimental to Our Practice?

Feat. V. Kumar
13:05
Sameer Gafoor

LAA Closure in 2016: How to Start a LAA Closure Program in Light of …

09:04
Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

Now That Physician Income From Medicare is Public Knowledge, Are We …

Feat. V. Kumar
13:23
Comprehensive Arterial and Venous Endovascular Conference (CVC) 2016

Medicare and the "World of MACRA"

Feat. V. Bufalino
07:21
New Cardiovascular Horizons (NCVH) 2015

Carotid Stenting is Overregulated: Will CMS Ever Change Their View?

Feat. C. White
09:50
Piedmont's Marcus Heart Valve Center

Preparing for MACRA: Michael Valentine and Charles Brown at Napa

12:20
Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

The New Medicare and its Impending Audits: How to Survive

Feat. V. Bufalino